Patent · US Active

Using nucleic acids encoding NAP-2 polypeptides to improve cardiac function

US11413330B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

Mayo Foundation for Medical Education and Research · US

Inventors

Atta Behfar · Rochester, US
Andre Terzic · Rochester, US
Ruben Jose Crespo-Diaz · Rochester, US

Key dates

Filing date	Jun 3, 2020
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Sep 16, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk for experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCT) for ST-elevation myocardial infarction (STEMI) are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.